Sulforaphane for treating or reducing insulin resistance of the liver
US9597307B2 · kind B2 · utility
0Cited by
1References
14Claims
0Family size
Inventors
Key dates
| Filing date | Nov 19, 2013 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Nov 19, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides sulforaphane, or a plant extract comprising sulforaphane, for treating or reducing insulin resistance of the liver. Especially, there is provided sulforaphane, or a plant extract comprising sulforaphane, for treating or reducing insulin resistance of the liver, wherein, in the subject to be treated, the insulin resistance index of the liver is higher than the insulin resistance of other metabolic tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.